Furasol

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT FURASOL (FURASOL)

Composition:

Active substance: soluble furacilin;

1 sachet contains 0.1 g of soluble furacilin;

Excipient: sodium chloride.

Dosage form. Mouthwash, powder.

Main physicochemical properties: coarse powder of orange-brown color.

Pharmacotherapeutic group.

Preparations used for throat disorders. Antiseptics.

ATC code R02A A20.

Pharmacological properties.

Pharmacodynamics.

Soluble furagin has a broad spectrum of antibacterial activity against gram-positive and gram-negative microorganisms, including strains of pathogenic staphylococci and other microorganisms resistant to antibiotics and other chemotherapeutic agents.

Compared to antibiotics and sulfonamides, resistance to soluble furagin develops slowly and to a minor extent.

Nitrofurans, including soluble furagin, inhibit the enzyme systems of microorganisms and also slow down other biochemical processes in microbial cells, leading to destruction of the bacterial cell wall or cytoplasmic membrane. Nitrofurans improve leukopoiesis, enhance the ability of leukocytes to phagocytize, and promote the granulation process. Soluble furagin is effective in the treatment of all types of purulent infections (including external ones). When applied to the skin or mucous membranes, it does not cause irritation or pain sensations.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications.

Inflammation of the oral cavity and pharynx. Infected wounds, burns, and purulent inflammations.

Contraindications.

Hypersensitivity (allergy) to furaginum solubile and drugs of the nitrofuran series.

Allergic dermatitis.

Do not use for rinsing the mouth and throat in children under 4 years of age (since a child cannot yet rinse the mouth and throat independently).

Interaction with other medicinal products and other forms of interaction.

In combination with antibiotics, exhibits a pronounced synergistic effect.

The use of alcohol during treatment with Furacilin increases the likelihood of developing skin allergic reactions.

Instructions for use.

Use the solution immediately after preparation.

Discoloration of the skin/mucous membrane to yellow may occur during use of the solution.

The risk of developing skin allergic reactions increases with alcohol consumption during treatment.

Use during pregnancy or breastfeeding.

Do not use. There are no data from controlled clinical studies on the use of the medicinal product during pregnancy and breastfeeding.

Ability to influence reaction rate when driving or operating machinery.

No effect.

Method of administration and dosage.

Prepare the solution immediately before use.

Inflammation of the oral cavity and throat

Dissolve the contents of one sachet in a glass (200 ml) of hot water. Use the warm solution to rinse the mouth and throat 2─3 times daily. Do not store the prepared solution.

Infected wounds, burns, and purulent inflammations

Dissolve the contents of one sachet in a glass (200 ml) of hot boiled or distilled water. Apply the warm solution for treating infected wounds, burns, and purulent inflammations 1─2 times daily.

Children.

Do not use for mouth and throat rinsing in children under 4 years of age, as children of this age are unable to rinse their mouth and throat independently.

Overdose.

The drug is low in toxicity. Cases of overdose have not been reported.

Adverse reactions.

Furasol is generally well tolerated. In individual cases, allergic reactions (rash, itching) may occur due to hypersensitivity to the components of the drug.

Shelf life.

5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

1 g of the drug in a laminate sachet; 5 or 15 sachets in a cardboard box.

Availability.

Over-the-counter.

Manufacturer

JSC "Olfa"/Olpha AS.

Manufacturer's address.

Rupnicu iela 5, Olaine, Olines novads, LV-2114, Latvia.